MEASURE Evaluation Phase III
MEASURE Evaluation Phase III continues the MEASURE program's 10 year initiative to improve the collection, analysis and presentation of data to promote better use in planning, policymaking, managing, monitoring and evaluating of population, health and nutrition programs. The program aims to accomplish this through achieving the following six results: (1) increased user demand for data and tools; (2) increased individual and institutional capacity in monitoring and evaluation; (3)increased collaboration and coordination in obtaining and sharing health sector data; (4) improved tools, methodologies and technical guidance; (5) increased availability of data, methods and tools; and (6) increased facilitation of data use. MEASURE Evaluation Phase III is the Global Health Bureaus primary vehicle for supporting improvements in monitoring and evaluation in population, health and nutrition worldwide.
Reduce the transmission and impact of HIV/AIDS through support for prevention, care and treatment programs. Expand access to high-quality voluntary family planning (FP) services and information, and reproductive health (RH) care. This element contributes to reducing unintended pregnancy and promoting healthy reproductive behaviors of men and women, reducing abortion, and reducing maternal and child mortality and morbidity.
- ID Projet
US-GOV-1-LR-AID-GHA-A-00-08-00003- Statut de l'activité
- 3 - Completion
- Type d'aide
- C01 - Interventions de type projet
- % to Libéria
- 100.00
Organisations
- Accountable
- U.S. Agency for International Development
- Extending
- U.S. Agency for International Development
- Funding
- U.S. Agency for International Development
- Implementing
- University of North Carolina, Chapel Hill
Versements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2015 |
Q1 |
103,960.09 |
103,960.09 |
| 2013 |
Q4 |
194,287.86 |
194,287.86 |
| 2013 |
Q3 |
347,721.77 |
347,721.77 |
| 2013 |
Q1 |
75,000.00 |
75,000.00 |
| 2012 |
Q2 |
500,000.00 |
500,000.00 |
| 2012 |
Q1 |
7,146,709.71 |
7,146,709.71 |
| 2011 |
Q4 |
6,458,290.29 |
6,458,290.29 |
| 2011 |
Q3 |
9,323,000.00 |
9,323,000.00 |
| 2011 |
Q2 |
7,896,834.51 |
7,896,834.51 |
| 2011 |
Q1 |
7,503,665.49 |
7,503,665.49 |
| 2010 |
Q4 |
6,930,000.00 |
6,930,000.00 |
| 2010 |
Q3 |
5,793,000.00 |
5,793,000.00 |
| 2010 |
Q2 |
7,901,000.00 |
7,901,000.00 |
| 2010 |
Q1 |
3,948,000.00 |
3,948,000.00 |
| 2009 |
Q4 |
5,954,000.00 |
5,954,000.00 |
| 2009 |
Q3 |
4,490,000.00 |
4,490,000.00 |
| 2009 |
Q2 |
5,332,750.00 |
5,332,750.00 |
| 2009 |
Q1 |
5,667,000.00 |
5,667,000.00 |
| 2008 |
Q4 |
3,898,800.00 |
3,898,800.00 |
| 2008 |
Q3 |
1,570,742.26 |
1,570,742.26 |
| 2008 |
Q2 |
4,307.74 |
4,307.74 |
Engagements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2012 |
Q1 |
16,457,809.00 |
16,457,809.00 |
| 2011 |
Q4 |
1,903,500.00 |
1,903,500.00 |
| 2011 |
Q3 |
11,309,448.00 |
11,309,448.00 |
| 2011 |
Q1 |
23,015,183.00 |
23,015,183.00 |
| 2010 |
Q4 |
3,717,993.00 |
3,717,993.00 |
| 2010 |
Q2 |
3,090,000.00 |
3,090,000.00 |
| 2010 |
Q1 |
29,332,350.00 |
29,332,350.00 |
| 2009 |
Q4 |
1,542,001.00 |
1,542,001.00 |
| 2009 |
Q3 |
660,000.00 |
660,000.00 |
| 2009 |
Q2 |
1,150,000.00 |
1,150,000.00 |
| 2009 |
Q1 |
21,181,500.00 |
21,181,500.00 |
| 2008 |
Q4 |
150,000.00 |
150,000.00 |
| 2008 |
Q3 |
350,000.00 |
350,000.00 |
| 2008 |
Q1 |
24,085,490.00 |
24,085,490.00 |
Projections de CDMT par exercice fiscal
| Exercice fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2014 |
170,000.00 |
170,000.00 |
| 2013 |
113,333.33 |
113,333.33 |
| 2012 |
113,333.33 |
113,333.33 |
| 2011 |
113,333.33 |
113,333.33 |
| 2010 |
113,333.33 |
113,333.33 |
| 2009 |
113,333.33 |
113,333.33 |
| 2008 |
113,333.33 |
113,333.33 |
| Code CRS |
% |
|
Inconnu
(0)
|
100.0
|